Silo Pharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Silo Pharma and other ETFs, options, and stocks.

About SILO

Silo Pharma, Inc. is a developmental stage biopharmaceutical company, which engages in the merging of traditional therapeutics with psychedelic research. It seeks to acquire and develop intellectual property or technology rights from universities and researchers to treat rare diseases, including the use of psychedelic drugs. 

CEO
Eric Weisblum
CEOEric Weisblum
Employees
3
Employees3
Headquarters
Sarasota, Florida
HeadquartersSarasota, Florida
Founded
2010
Founded2010
Employees
3
Employees3

SILO Key Statistics

Market cap
5.68M
Market cap5.68M
Price-Earnings ratio
-0.66
Price-Earnings ratio-0.66
Dividend yield
Dividend yield
Average volume
19.19M
Average volume19.19M
High today
$0.42
High today$0.42
Low today
$0.3816
Low today$0.3816
Open price
$0.418
Open price$0.418
Volume
544.11K
Volume544.11K
52 Week high
$1.19
52 Week high$1.19
52 Week low
$0.221
52 Week low$0.221

Stock Snapshot

With a market cap of 5.68M, Silo Pharma(SILO) trades at $0.39. The stock has a price-to-earnings ratio of -0.66.

On 2026-04-14, Silo Pharma(SILO) stock moved within a range of $0.38 to $0.42. With shares now at $0.39, the stock is trading +1.6% above its intraday low and -7.7% below the session's peak.

Trading activity shows a volume of 544.11K, compared to an average daily volume of 19.19M.

The stock's 52-week range extends from a low of $0.22 to a high of $1.19.

The stock's 52-week range extends from a low of $0.22 to a high of $1.19.

People also own

Based on the portfolios of people who own SILO. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.